Stem Cell Expansion

NOVEL STEM CELL EXPANSION TECHNOLOGY

Coeptis holds the rights to a scalable allogeneic immune effector cell manufacturing platform that aligns with our existing SNAP-CAR technology. These immune effector cells are generated from pooled, cord blood derived CD34+ cells.

CORD BLOOD DERIVED HSPCs

Cord blood derived hematopoietic stem and progenitor cells (HSPCs) offer natural killer (NK) cells multiple benefits including: no genetic modification needed for the source blood, cellular typing is not required, and the source blood is in plentiful supply.

SIMPLE, SCALABLE, COST-EFFECTIVE AND OFF THE SHELF

Through this novel platform, notch mediated CD34+ cell expansion and direction differentiation allow for NK cells to be produced with improved lot-to-lot consistency, and with greater opportunity for multiple successful tech transfers. Additionally, hundreds of doses can be generated when manufacturing at full scale. These therapies result in a potent NK cell product for use as an off-the-shelf product, with fixed doses fully released and ready for infusion on the patient’s timeline.

CONTACT US

LEARN MORE

Coeptis Holdings, Inc.
info@coeptistx.com

ABOUT

OUR SCIENCE

SNAP-CAR

CAREERS

NEWS

CONTACT

This section of our website may contain dated or archived information that should not be considered current and may no longer be accurate. For the most up-to-date information about our company, please refer to our latest official communications and materials. Certain statements contained in our releases, events, and presentations that are not historical facts are forward-looking statements. These statements involve risks and uncertainties, including, but not limited to, the outcomes of research and development activities, results of preclinical and clinical studies, regulatory considerations, the impact of competitive products, product development and commercialization challenges, technological factors, and other risks inherent to our business. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date they are made, except as required by applicable law. This website may contain links to third-party websites for convenience. The inclusion of any such links does not imply endorsement of the content, products, or services offered by those third parties. We do not control and are not responsible for the content, accuracy, or functionality of any third-party websites.